Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Episode 18 with Dr. Samuel Ludwin on new approaches to remyelination therapies.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
MS clinical trials: what can subgroup analyses teach us?
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
Keystone Symposium: Dendritic Cells and Macrophages Reunited
Episode 7 with Dr. Daniel Kantor on access to care
Episode 10 with Dr. Richard Ransohoff on his group's latest research
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
ForuMS: A Virtual Journal Club for MS Clinicians
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
Masitinib mesylate application for conditional approval
The force awakens: insights into the origin and formation of microglia.
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
46th Annual WCBR Winter Conference on Brain Research
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
US and EU regulatory authorities accept oral BG-12 marketing applications for review

Pages